Articles > Business magazines > Specialty and Local Interest magazines > BT Catalyst articles > January-March 2002 > Friday, February 1

Article: Salix submits NDA for Rifaximin.

Article from:
BT Catalyst
Article date:
February 1, 2002
Copyright

Salix Pharmaceuticals Ltd. (Nasdaq: SLXP) of Raleigh has submited a New Drug Application for rifaximin to the U.S. Food and Drug Administration. Salix is seeking approval to market rifaximin for the treatment of travelers' diarrhea.

Rifaximin is a novel, broad-spectrum antibiotic. It is chemically structured to deliver high concentrations of antibiotic to the gastrointestinal tract while ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Ligand and Alfa Wassermann Enter Into Marketing and ...
Business Wire;  January 6, 2000 ;     700+ words ... ... marketing and distribution agreement with Alfa Wassermann S.p.A. to exclusively market ... This strategic partnership with Alfa Wassermann is the second step in what we intend ... with enthusiasm the relationship with Alfa Wassermann as we plan and execute the registration ...

Article: Alfa Wassermann Diagnostic Technologies and Hitachi ...
Business Wire;  May 29, 2007 ;     700+ words ... ... CALDWELL, N.J. & TOKYO -- Alfa Wassermann Diagnostic Technologies, LLC and ... point of care. To address this need, Alfa Wassermann and Hitachi have entered into a distribution ... partnership: Douglas Danne, President of Alfa Wassermann Diagnostic Technologies, LLC, said ...

Article: ADDING and REPLACING Alfa Wassermann Proteomic ...
Business Wire;  November 29, 2006 ;     700+ words ... ... purposes. The release reads: ALFA WASSERMANN PROTEOMIC TECHNOLOGIES, LLC ANNOUNCES ... WITH PRESSURE BIOSCIENCES, INC. Alfa Wassermann Proteomic Technologies, LLC, (AWPT), a division of Alfa Wassermann Inc, announces an agreement with ...

Article: Pressure BioSciences, Inc. Announces Collaboration with ...
Business Wire;  November 29, 2006 ;     700+ words ... ... signed a collaboration agreement with Alfa Wassermann Proteomic Technologies, LLC (AWPT ... 01. Dino DiCamillo, President of Alfa Wassermann Proteomic Technologies, said ... Established in January 2004 as a division of Alfa Wassermann, Inc. (AWI), AWPT leverages and ...

Article: Corporate Profile for Alfa Wassermann SPA, dated ...
Business Wire;  April 21, 2000 ;     700+ words ... ... Date: April 21, 2000 Company Name: Alfa Wassermann SPA Address: Vale Sarca 223 Milano ... Pharmaceutical Company description: Alfa Wassermann Group is a mid-size, Italian privately ... Ethical Pharmaceuticals have been Alfa Wassermann's core business from its inception ...

Article: Keryx Biopharmaceuticals Settles License Dispute With Alfa ...
PR Newswire;  August 4, 2009 ;     700+ words ... ... Data and Intellectual Property to Alfa Wassermann NEW YORK, Aug. 4 /PRNewswire ... announced today that the Company and Alfa Wassermann S.p.A. have settled a dispute ... terms of the settlement agreement, Alfa Wassermann is paying Keryx US$3,500,000 ...

Article: Axcan purchases patents on new, better absorbed Ursodiol ...
PR Newswire;  January 5, 2001 ;     700+ words ... ... today that it has signed an agreement with Alfa-Wassermann SpA ("Alfa- Wassermann"), to purchase several patents on novel ... Pilot studies previously conducted by Alfa-Wassermann demonstrated that the bioavailability of ...

Article: ALFA WASSERMANN S.p.A.-Company Report.
M2 Presswire;  January 26, 2009 ;     531 words ... ... PRESSWIRE-26 January 2009-www.companiesandmarkets.com: ALFA WASSERMANN S.p.A.-Company Report(C)1994-2009 M2 COMMUNICATIONS ... 26012009 -www.companiesandmarkets.com adds new report: ALFA WASSERMANN S.p.A.-Company Report Private Company Reports provide ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives